Prosecution Insights
Prosecution Insights
11 pending office actions • 8 art units • 11 examiners • 0 of 11 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 11 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 11 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 7 (64%) |
| §102 only | 1 (9%) |
| No statute on record | 3 (27%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAMACHANDRAN, UMAMAHESWARI | 1 | 54.5% | +53.7% |
| VALENROD, YEVGENY | 1 | 72.6% | +25.4% |
| LANDSMAN, ROBERT S | 1 | 81.3% | +12.9% |
| WHITEMAN, BRIAN A | 1 | 68.2% | +17.0% |
| O'NEILL, MARISOL ANN | 1 | 52.2% | +64.7% |
| HERNANDEZ, JACKSON J | 1 | 52.8% | +51.5% |
| PYLA, EVELYN Y | 1 | 55.1% | +47.8% |
| SUNSHINE, HANNAH LOUISE | 1 | 71.0% | +13.3% |
| RIGA, MICHAEL ANGELO | 1 | 51.8% | +63.5% |
| SINGH, ANOOP KUMAR | 1 | 42.8% | +67.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18245257 | METHODS FOR TREATING OR MODULATING AN INFLAMMATORY RESPONSE | LANDSMAN, ROBERT S | 24d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18015657 | SUBSTITUTED 4-(3-AMINOPROP-1-YL)AMINOQUINOLINE ANALOGS AS MODULATORS OF MELANOMA-ASSOCIATED ANTIGEN 11 UBIQUITIN LIGASE | HERNANDEZ, JACKSON J | 104d overdue |
| 17917198 | B7-H3 CHIMERIC ANTIGEN RECEPTORS | RIGA, MICHAEL ANGELO | 72d overdue |
| 17636152 | SCHIZOPHRENIA-RELATED MICRODELETION GENE 2510002D24Rik IS ESSENTIAL FOR SOCIAL MEMORY | SINGH, ANOOP KUMAR | 59d overdue |
| 18245257 | METHODS FOR TREATING OR MODULATING AN INFLAMMATORY RESPONSE | LANDSMAN, ROBERT S | 24d overdue |
| 18642382 | METHODS OF TREATING DISORDERS ASSOCIATED WITH CASTOR | RAMACHANDRAN, UMAMAHESWARI | 16d overdue |
| 18541691 | COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF HEARING LOSS | VALENROD, YEVGENY | 11d overdue |
| 18042015 | COMPOSITIONS AND METHOD FOR TREATING THALASSEMIA | WHITEMAN, BRIAN A | 2d overdue |
| 18041873 | Use of Amylase or Maltose to Treat or Prevent Neurodegeneration | O'NEILL, MARISOL ANN | 9d |
| Art Unit | Apps |
|---|---|
| 1627 | 2 |
| 1647 | 2 |
| 1633 | 2 |
| 1628 | 1 |
| 1636 | 1 |
| 1634 | 1 |
| 1632 | 1 |
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18642382 | METHODS OF TREATING DISORDERS ASSOCIATED WITH CASTOR | RAMACHANDRAN, UMAMAHESWARI | 1627 | Other | Final Rejection | 16d overdue | Pending | Apr 22, 2024 |
| 18541691 | COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF HEARING LOSS | VALENROD, YEVGENY | 1628 | Other | Non-Final OA | 11d overdue | Pending | Dec 15, 2023 |
| 18245257 | METHODS FOR TREATING OR MODULATING AN INFLAMMATORY RESPONSE | LANDSMAN, ROBERT S | 1647 | §102 | Non-Final OA | 24d overdue | Pending | Mar 14, 2023 |
| 18042015 | COMPOSITIONS AND METHOD FOR TREATING THALASSEMIA | WHITEMAN, BRIAN A | 1636 | §103 | Non-Final OA | 2d overdue | Pending | Feb 17, 2023 |
| 18041873 | Use of Amylase or Maltose to Treat or Prevent Neurodegeneration | O'NEILL, MARISOL ANN | 1633 | §103 | Final Rejection | 9d | Pending | Feb 16, 2023 |
| 18015657 | SUBSTITUTED 4-(3-AMINOPROP-1-YL)AMINOQUINOLINE ANALOGS AS MODULATORS OF MELANOMA-ASSOCIATED ANTIGEN 11 UBIQUITIN LIGASE | HERNANDEZ, JACKSON J | 1627 | §103 | Non-Final OA | 104d overdue | Pending | Jan 11, 2023 |
| 17927038 | Recombinant P5 Promoter for Use in Reducing DNA Contamination of AAV Preparations | PYLA, EVELYN Y | 1633 | §103 | Non-Final OA | 28d | Pending | Nov 22, 2022 |
| 17918644 | CHIMERIC MYD88 RECEPTORS | SUNSHINE, HANNAH LOUISE | 1647 | §103 | Final Rejection | 34d | Pending | Oct 13, 2022 |
| 17917198 | B7-H3 CHIMERIC ANTIGEN RECEPTORS | RIGA, MICHAEL ANGELO | 1634 | §103 | Non-Final OA | 72d overdue | Pending | Oct 05, 2022 |
| 17636152 | SCHIZOPHRENIA-RELATED MICRODELETION GENE 2510002D24Rik IS ESSENTIAL FOR SOCIAL MEMORY | SINGH, ANOOP KUMAR | 1632 | §103 | Final Rejection | 59d overdue | Pending | Feb 17, 2022 |
| 17550051 | Use of FOXP3 Enhancers to Modulate Regulatory T Cells | WILSON, MICHAEL C | 1638 | — | Final Rejection | 2d overdue | Pending | Dec 14, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial